Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization

Published:2018-06 Issue: Volume:9 Page:1-11
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Schnabolk Gloriane,Parsons Nathaniel,Obert Elisabeth,Annamalai Balasubramaniam,Nasarre Cecile,Tomlinson Stephen,Lewin Alfred S.,Rohrer Bärbel

Funder

Department of Veterans Affairs

NIH

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference63 articles.

1. The status of RPE65 gene therapy trials: safety and efficacy;Pierce;Cold Spring Harb. Perspect. Med.,2015

2. Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial;Heier;Lancet,2017

3. DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice;Han;J. Clin. Invest.,2012

4. RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma;Li;Diagn. Pathol.,2009

5. Erythropoietin slows photoreceptor cell death in a mouse model of autosomal dominant retinitis pigmentosa;Rex;PLoS ONE,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart Nanocarriers for the Treatment of Retinal Diseases;ACS Applied Bio Materials;2024-03-15

2. AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies;BioDrugs;2023-10-25

3. The complement system: a novel therapeutic target for age-related macular degeneration;Expert Opinion on Pharmacotherapy;2023-09-27

4. A guide to complement biology, pathology and therapeutic opportunity;Nature Reviews Immunology;2023-09-05

5. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model;Translational Vision Science & Technology;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3